Kazakhstan plans to increase COVID-19 tests, starts ventilators and protective suits production

Kazakhstan plans to increase COVID-19 tests, starts ventilators and protective suits production
Kazakhstan plans to increase the number of COVID-19 tests carried out in a day to 35,000. Currently, this figure amounts to 28,000 tests per day. In total, more than 1.2 million coronavirus tests have been conducted in the country since March, acting Health Minister of Kazakhstan Lyazat Aktayeva said at the government meeting. Currently, the COVID-19 testing is carried out when there are epidemiological indications, as well as for preventive purposes and as part of disease surveillance.
According to the Decree of the Kazakh Chief Sanitary Officer, the following individuals are subject for laboratory testing for novel coronavirus:

-COVID-19 patients and virus carriers
-Patients diagnosed with acute viral respiratory infections, influenza or pneumonia
-Contacts of COVID-19 patients
-Individuals hospitalized in medical facilities and hospitals
-Health workers
-Individuals entering the territory of the Republic of Kazakhstan.
“There are 78 COVID-19 tests available per patient in Kazakhstan. This figure is higher than in Russia, the United States, Italy, Canada and Austria. The number of coronavirus tests per 100,000 people stands at 6,824 there,” Aktayeva said.
In addition, Kazakhstan, together with Turkish and Chinese partners, will start the production of lung ventilation equipment, Kazakh Minister of Industry and Infrastructure Development Beibut Atamkulov stated at the government meeting.
“According to Kazakh Health Ministry, in the next six months, the need for ventilators will amount to 132 units. To date, 380 ventilators have been produced so far. Of these, 164 ventilators are ready for shipping and 216 are being tested at the factory. The remaining 200 ventilators will be produced and delivered by the end of July,” Atamkulov said.
He said that a Kazakh high-tech project of the BARK Technology LLP is in the working process. The company will complete its own development and will donate 20 ventilators for testing to the Kazakh Health Ministry. The remaining 112 ventilators will be produced in August or September of this year.
Atamkulov also said that it is planned to launch three enterprises producing protective suits in Kazakhstan by the end of this year.
“For the next six months, the need for protective suits in the country will amount to 1.3 million pieces. For these purposes, we plan to launch corresponding enterprises. We also plan to increase production volumes of the existing enterprises. All of these measures will bring the production of protective suits to 800,000 pieces per month. The need for medical gloves will amount to 83.7 million pairs. Currently, the two Kazakh enterprises produce 330,000 pairs of gloves per day. In the future, we plan to increase their production to 460,000 pairs per day,” Atamkulov added.
Kazakh Minister of Education and Science Askhat Aimagambetov said that systematic research is carried out in Kazakhstan in the field of biosafety and biotechnology. Twelve scientific organizations are involved in these scientific researches.  Nearly 2,500 people work in these organizations.
Aimagambetov further dwelled on the activities of the National Center for Biotechnology that manufactures COVID-19 testing systems.
“During the initial stage of the global pandemic, when the testing systems for the diagnosis of COVID-19 had not yet been imported, the specialists of the National Center for Biotechnology developed a reliable PCR-based coronavirus test system within only six days without having a viable strain of SARS-CoV-2 and therefore using the artificial synthesis. We managed to carry out a general diagnostic in the early days of the pandemic due to this test system. To date, the National Center for Biotechnology produced 11,000 COVID-19 test systems commissioned by Kazakh Health Ministry,” Aimagambetov said.
He also said that the Kazakh Research Institute for Biological Safety Problems is carrying out the work to combat dangerous infectious diseases.
“The Institute entered into agreement with the World Health Organization to develop the vaccines against especially dangerous infectious diseases for the needs of public health. The Institute’s work is aimed at developing new types of vaccines in medicine and agriculture, as well as producing immunobiological drugs and test systems for dangerous and highly dangerous infectious diseases,” Aimagambetov said. 
In addition, the scientists of the Kazakh Research Institute for Biological Safety Problems are currently developing five COVID-19 vaccines on three platforms. They plan to start clinical trials already in September.
Photo: hightech.fm